| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/27/2014 | WO2014030137A1 Vaccine strain marked with the plague virus of small ruminants, and preparation method thereof |
| 02/27/2014 | WO2014030019A1 A sreening method for identifying therapeutic agents in target cells |
| 02/27/2014 | WO2014030002A2 Molecularly imprinted polymers |
| 02/27/2014 | WO2014029976A1 Effluent monitoring systems |
| 02/27/2014 | WO2014029890A1 Method for predicting responsiveness to tnf antibody therapy |
| 02/27/2014 | WO2014029888A2 Branched or macrocyclic polyamines and uses thereof |
| 02/27/2014 | WO2014029816A1 Anti-c1q epitope elisa |
| 02/27/2014 | WO2014029792A1 Virus particle stabilisation and method for isolating viral nucleic acids |
| 02/27/2014 | WO2014029756A1 Cholyl-l-lysyl-fluorescein assay |
| 02/27/2014 | WO2014029736A1 Method for producing a sensor instrument, and sensor instrument |
| 02/27/2014 | WO2014029675A1 Method and device for measuring the gas content in a liquid, and use of such a device |
| 02/27/2014 | WO2014029663A1 Gas analysis apparatus and method |
| 02/27/2014 | WO2014029570A1 Sensor instrument |
| 02/27/2014 | WO2014029503A1 Method and apparatus for supporting the preservation of the insect population |
| 02/27/2014 | WO2014008206A3 DIAGNOSTIC AND THERAPEUTIC POTENTIAL OF HLA-E MONOSPECIFIC MONOCLONAL IgG ANTIBODIES DIRECTED AGAINST TUMOR CELL SURFACE AND SOLUBLE HLA-E |
| 02/27/2014 | WO2014007676A3 Method for determining the functional status of biological tissue |
| 02/27/2014 | WO2014006432A3 Control system for immunoprecipitation studies |
| 02/27/2014 | WO2014006397A3 Pore analysis |
| 02/27/2014 | WO2014006394A3 An electrode and use thereof |
| 02/27/2014 | WO2014006043A3 Device for spematozoa selection |
| 02/27/2014 | WO2014005168A3 Method for examination of a sample |
| 02/27/2014 | WO2014004609A3 Rapid assays for t-cell activation by rna measurements using flow cytometry |
| 02/27/2014 | WO2013192144A3 Rift valley fever virus replicon particles |
| 02/27/2014 | WO2013188600A9 Copy number aberration driven endocrine response gene signature |
| 02/27/2014 | WO2013184950A3 Kits for detecting and monitoring endocrine disrupting chemicals (edcs) |
| 02/27/2014 | WO2013181418A3 Multiplexed diagnosis method for classical hodgkin lymphoma |
| 02/27/2014 | WO2013175318A3 Microbead agglutination based assays |
| 02/27/2014 | WO2013175313A3 Methods and systems for the detection of ricin and other ribosome inactivating proteins |
| 02/27/2014 | WO2013172955A9 Tumor cell isolation/purification process and methods for use thereof |
| 02/27/2014 | WO2013172779A3 Method for indicating the presence or non-presence of prostate cancer |
| 02/27/2014 | WO2013153458A3 Method for the prognosis and treatment of cancer metastasis |
| 02/27/2014 | WO2013152989A3 Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer |
| 02/27/2014 | WO2013134786A3 Biomarker compositions and methods |
| 02/27/2014 | WO2013128285A9 Improved analytical methods for analyzing and determining impurities in dianhydrogalactitol |
| 02/27/2014 | WO2013103899A3 Phosphorylation of histones and uses thereof |
| 02/27/2014 | WO2013013302A8 Synthetic lethality and the treatment of cancer |
| 02/27/2014 | WO2012139069A3 Compositions and methods for treating diseases of protein aggregation involving ic3b deposition |
| 02/27/2014 | WO2012125553A3 N-acetylhexosamine-containing n-glycans in glycoprotein products |
| 02/27/2014 | WO2012122121A3 Signal amplification for immunoassays by use of avidin-biotin linkages |
| 02/27/2014 | WO2012092532A3 Protein biomarkers of late stage breast cancer |
| 02/27/2014 | US20140059712 Multiple-virus-resistant melon |
| 02/27/2014 | US20140058676 Digital rock analysis systems and methods that reliably predict a porosity-permeability trend |
| 02/27/2014 | US20140058000 Diagnostic markers for determining the predisposition to the development of cervical cancer and oligonucleotides used for the determination |
| 02/27/2014 | US20140057986 Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type |
| 02/27/2014 | US20140057967 Method of screening for chaperonin modulator |
| 02/27/2014 | US20140057966 Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors |
| 02/27/2014 | US20140057962 Compositions and Methods for the Treatment of Cancer |
| 02/27/2014 | US20140057960 Novel repressor on ifn-lambda promoter and sirna against zeb1 and blimp-1 to increase ifn-lambda gene activity |
| 02/27/2014 | US20140057955 Novel, protective, anti-inflammatory receptor and its use in preservation of mitochondrial function, wound healing and repair |
| 02/27/2014 | US20140057948 Vif as a target for hiv inhibition |
| 02/27/2014 | US20140057913 Aurora kinase inhibitors and methods of making and using thereof |
| 02/27/2014 | US20140057906 Modulators of atp-binding cassette transporters |
| 02/27/2014 | US20140057905 Cancer diagnostics, therapeutics, and drug discovery associated with macropinocytosis |
| 02/27/2014 | US20140057894 Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators |
| 02/27/2014 | US20140057865 Analysis of nodes in cellular pathways |
| 02/27/2014 | US20140057829 Citrullinated Histone H3 (Cit H3) in Septic Shock |
| 02/27/2014 | US20140057809 Miniaturized microparticles |
| 02/27/2014 | US20140057804 Cell Model and Method for Screening c-Fms Kinase Inhibitors |
| 02/27/2014 | US20140057803 Immunoassay reagents and methods of use thereof |
| 02/27/2014 | US20140057798 Prediction of drug sensitivity of lung tumors based on molecular genetic signatures |
| 02/27/2014 | US20140057796 Method for the Diagnosis, Prognosis and Treatment of Breast Cancer Metastasis |
| 02/27/2014 | US20140057368 Methods for determining ligand binding to a target protein using a thermal shift assay |
| 02/27/2014 | US20140057367 Assays for the detection of anti-tnf drugs and autoantibodies |
| 02/27/2014 | US20140057366 Sensor device for magnetically actuated particles |
| 02/27/2014 | US20140057365 Test device and method for colored particle immunoassay |
| 02/27/2014 | US20140057359 Apparatus and method for analyzing sample fluids |
| 02/27/2014 | US20140057358 Analysis of sulfated polysaccharides |
| 02/27/2014 | US20140057357 Method for quantitatively detecting 8-oxo 2'-deoxyguanosine in aqueous sample solution with high sensitivity |
| 02/27/2014 | US20140057356 Estimating diffusion coefficient for a reservoir stimulation fluid |
| 02/27/2014 | US20140057315 Antigen presenting cell assay |
| 02/27/2014 | US20140057313 Methods for Making Cells with an Extra-Embryonic Endodermal Precursor Phenotype |
| 02/27/2014 | US20140057312 Fluorescent probe |
| 02/27/2014 | US20140057311 Device For High Throughput Investigations Of Multi-Cellular Interactions |
| 02/27/2014 | US20140057310 Label Free Biosensors And Cells |
| 02/27/2014 | US20140057309 Method for determining endogenous and exogenous markers in blood |
| 02/27/2014 | US20140057308 Method for detecting protein s abnormalites |
| 02/27/2014 | US20140057307 Method for the diagnosis of dry eye and blepharitis |
| 02/27/2014 | US20140057306 Antibodies to Quetiapine and Use Thereof |
| 02/27/2014 | US20140057305 Antibodies to Quetiapine Haptens and Use Thereof |
| 02/27/2014 | US20140057304 Antibodies to Olanzapine and Use Thereof |
| 02/27/2014 | US20140057303 Antibodies to Olanzapine Haptens and Use Thereof |
| 02/27/2014 | US20140057302 Antibodies to Risperidone and Use Thereof |
| 02/27/2014 | US20140057301 Antibodies to Risperidone Haptens and Use Thereof |
| 02/27/2014 | US20140057300 Antibodies to Aripiprazole and Use Thereof |
| 02/27/2014 | US20140057299 Antibodies to Aripiprazole Haptens and Use Thereof |
| 02/27/2014 | US20140057298 Antibodies to Paliperidone and Use Thereof |
| 02/27/2014 | US20140057297 Antibodies to Paliperidone Haptens and Use Thereof |
| 02/27/2014 | US20140057296 Assays for antibodies which bind to therapeutic agents |
| 02/27/2014 | US20140057295 Anti-mullerian hormone changes in pregnancy and prediction of adverse pregnancy outcomes and gender |
| 02/27/2014 | US20140057293 Conjugates of 1,4,7-triazacyclononanes, dinuclear metal complexes of such conjugates, and methods of use for both 1,4,7-triazacyclononanes and conjugates |
| 02/27/2014 | US20140057292 Immunochromatographic Device |
| 02/27/2014 | US20140057290 Method for performing a biochemical analysis, especially in outer space |
| 02/27/2014 | US20140057288 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease |
| 02/27/2014 | US20140057287 Novel cardiomyocyte marker |
| 02/27/2014 | US20140057286 Method for Measuring Glycoprotein, Method for Examining Liver Desease, Reagent for Quantitative Determination of Glycoprotein and Glycan-Marker Glycoprotein as an Index for Clinical Conditions of Liver Disease |
| 02/27/2014 | US20140057285 Compositions and methods targeting force generation in kinesin |
| 02/27/2014 | US20140057281 Method of producing retinal pigment epithelial cell sheet |
| 02/27/2014 | US20140057269 Materials and Methods for Detection of Nucleic Acids |
| 02/27/2014 | US20140057267 Composition and kit for the diagnosis of mild cognitive impairment, which measure an expression level of lipocalin-2, and method for providing information for the diagnosis of mild cognitive impairment |
| 02/27/2014 | US20140057261 Methods of diagnosing, classifying and treating endometrial cancer and precancer |